Medicare Part B covers Leqembi for people with early Alzheimer's or mild cognitive impairment. Learn more about Leqembi and Medicare coverage here.

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Aliada Therapeutics. With the completion of the ...

Research finds some older adults have substantial signs of the disease inside the brain but never have symptoms.

How new science is finding new drugs and new approaches to fight Alzheimer's Disease, the number seven killer in America.

It sees advancements with new drug classes like cholinesterase inhibitors. The global Alzheimer's disease therapeutics market ...

Black older adults who frequently attend religious services are significantly less likely to develop Alzheimer’s or related ...

SA announced interim safety and tolerability data from the ABATE Phase 1b/2 trial of ACI-24.060 in individuals living with ...

AC Immune Reports Interim Safety Data from Phase 1b/2 ABATE Trial of ACI-24.060 in Down syndrome ACI-24.060 was generally safe and well tolerated ...

According to the National Institutes of Health, 30-50% of brains donated to research as “controls” or healthy end up having these markers of Alzheimer’s. The older individuals, with an average age of ...

A study by the team of Prof. Kristel Sleegers (VIB-UAntwerp), published in Acta Neuropathologica, has offered new insights ...

New research suggests Alzheimer's drugs may improve cognition by increasing Aβ42 levels rather than just reducing plaques, ...

The darlings of the weight loss and diabetes spaces, GLP-1 receptor agonists have shown promise against Alzheimer’s in recent studies—with Phase III results expected next year from Novo Nordisk.